Thomas Devlin

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Cross Sectional

Placebo Controlled

Acute Ischemic Stroke

Top Venues

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

A-Ching Chao, Tsong-Hai Lee, Luther C Pettigrew, Yousef Hannawi, Hung-Yu Huang, Nai-Fang Chi, Lung Chan, Po-Lin Chen, Thomas Devlin
Intravenous Odatroltide for Acute Ischemic Stroke Within 24 Hours of Onset: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study. Drug design, development and therapy 18 (2024)
A-Ching Chao, Tsong-Hai Lee, Luther C Pettigrew, Yousef Hannawi, Hung-Yu Huang, Nai-Fang Chi, Lung Chan, Po-Lin Chen, Thomas Devlin
Intravenous Odatroltide for Acute Ischemic Stroke Within 24 Hours of Onset: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study. Drug design, development and therapy 18 (2024)
A-Ching Chao, Tsong-Hai Lee, Luther C Pettigrew, Yousef Hannawi, Hung-Yu Huang, Nai-Fang Chi, Lung Chan, Po-Lin Chen, Thomas Devlin
Intravenous Odatroltide for Acute Ischemic Stroke Within 24 Hours of Onset: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study. Drug design, development and therapy 18 (2024)